{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:11:43Z","timestamp":1787069503348,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.path.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T06:56:50Z","timestamp":1686466610000},"page":"443-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["How Hepatologists Use Liver Biopsy in the Evaluation of Liver Disease?"],"prefix":"10.1016","volume":"16","author":[{"given":"Emilie K.","family":"Mitten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.path.2023.04.001_bib2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","article-title":"Abnormal liver enzymes: A review for clinicians","volume":"13","author":"Kalas","year":"2021","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MOG.0000000000000621","article-title":"The utility of liver biopsy in 2020","volume":"36","author":"Khalifa","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tige.2021.09.002","article-title":"EUS Guided Liver Biopsy","volume":"24","author":"Obaitan","year":"2022","journal-title":"Techniques and Innovations in Gastrointestinal Endoscopy"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10620-014-3346-5","article-title":"Gaps in recognition and evaluation of incidentally identified hepatic steatosis","volume":"60","author":"Wright","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cgh.2017.06.050","article-title":"Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?","volume":"16","author":"Tana","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.path.2023.04.001_bib7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib8","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2017.03.017","article-title":"American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis","volume":"152","author":"Lim","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.path.2023.04.001_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib12","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.path.2023.04.001_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32591","article-title":"Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis","author":"Harrington","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.path.2023.04.001_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG Clinical Guideline: Primary Sclerosing Cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.path.2023.04.001_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2018.06.082","article-title":"Gastrointestinal and Extra-Intestinal Manifestations of IgG4-Related Disease","volume":"155","author":"Miyabe","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.path.2023.04.001_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cld.505","article-title":"Systemic disease associated with noncirrhotic portal hypertension","volume":"6","author":"Semela","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cld.497","article-title":"Noncirrhotic portal hypertension: An overview","volume":"6","author":"Etzion","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib21","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/hep.30167","article-title":"Liver Stiffness Measurements in Patients with Noncirrhotic Portal Hypertension-The Devil Is in the Details","volume":"68","author":"Vuppalanchi","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cld.2014.01.009","article-title":"Non-cirrhotic portal hypertension","volume":"18","author":"Sarin","year":"2014","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cld.1092","article-title":"Alcoholic Hepatitis","volume":"18","author":"Gougol","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2019.05.020","article-title":"Natural history of histologically proven alcohol-related liver disease: A systematic review","volume":"71","author":"Parker","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cld.1129","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Patient-Friendly Summary of the 2019 AASLD Guidelines","volume":"17","author":"Bertha","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: Alcoholic Liver Disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.path.2023.04.001_bib28","first-page":"396","article-title":"Prevalence and significance of autoantibodies in patients with alcoholic liver disease","volume":"14","author":"Lian","year":"2013","journal-title":"J\u00a0Dig Dis"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13556210050003720","article-title":"Autoantibodies in alcoholic liver disease","volume":"5","author":"McFarlane","year":"2000","journal-title":"Addict Biol"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.path.2023.04.001_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"10290","key":"10.1016\/j.path.2023.04.001_bib32","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort","volume":"75","author":"Harrison","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.path.2023.04.001_bib35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.path.2023.04.001_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.path.2023.04.001_bib37","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.path.2023.04.001_bib38","doi-asserted-by":"crossref","first-page":"e1912565","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.path.2023.04.001_bib40","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib41","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.path.2023.04.001_bib42","first-page":"357","article-title":"Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic","volume":"15","author":"Pandyarajan","year":"2019","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib43","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.path.2023.04.001_bib44","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/acem.14174","article-title":"Hepatic Steatosis: An Incidental Finding That Deserves Attention","volume":"28","author":"Kontrick","year":"2021","journal-title":"Acad Emerg Med"},{"issue":"2","key":"10.1016\/j.path.2023.04.001_bib45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.14309\/ajg.0000000000001054","article-title":"Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations","volume":"116","author":"Younossi","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12072-011-9277-8","article-title":"Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network","volume":"6","author":"Vuppalanchi","year":"2012","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.path.2023.04.001_bib47","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.path.2023.04.001_bib49","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.14309\/ajg.0000000000001337","article-title":"Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis","volume":"116","author":"Castellana","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2023.04.001_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"American Association for the Study of Liver D. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.path.2023.04.001_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/17474124.2018.1496016","article-title":"Hemochromatosis: pathophysiology, evaluation, and management of hepatic iron overload with a focus on MRI","volume":"12","author":"Golfeyz","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib52","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: An update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.path.2023.04.001_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","article-title":"EASL Clinical Practice Guidelines: Wilson's disease","volume":"56","author":"European Association for Study of","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cld.896","article-title":"Update on Alpha-1 Antitrypsin Deficiency in Liver Disease","volume":"15","author":"Narayanan","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib55","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin Pi\u2217Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.path.2023.04.001_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2205416","article-title":"Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency","volume":"387","author":"Strnad","year":"2022","journal-title":"N\u00a0Engl J Med"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:40Z","timestamp":1761749020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1875918123000272"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.04.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How Hepatologists Use Liver Biopsy in the Evaluation of Liver Disease?","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}